Recital 15, Regulation (EU) 2024/324

In forcesince 19 Jan 2024

As the Authority requested additional information for the purposes of assessment of the approval criteria set out in points 3.6.5 and 3.8.2 of Annex II to Regulation (EC) No 1107/2009 for the active substance fluazinam, and in light of the time required to complete the remaining steps in the renewal procedure, the duration of the extension of the approval period for this active substance should be set at 25 months and 2 weeks.